DrugsControl Media Services
DrugsControl.org

News Detail

Recall of Abbott neurostimulation devices after MRI-related issues lead to 73 injuries (15-09-2023)

Maryland, 14 Sept 2023: The U.S. Food and Drug Administration (FDA) has View Details

Source : Health Imaging
Magnetic Resonance Imaging Policy & Regulations Abbott Proclaim and Infinity neurostimulation systems Class I recall

Related News